Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.
Nat Biotechnol
; 40(8): 1270-1275, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35241839
Full text:
1
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Year:
2022
Type:
Article